MENU
ADVM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Adverum Biotechnologies (ADVM) Ownership - Who owns Adverum Biotechnologies?
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
100 Cardinal Way
Phone
+1 650 659-9323
Employees
121
Web
https://www.adverum.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
65.18M
P/E Ratio
N/A
Total Cash
153.24M
Projected Growth
N/A
Total Debt
73.26M
Revenue
1M
Risk (Beta)
1.27
Dividend Yield
N/A
Total Cash/Share
7.34
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price
Fundamentals
ADVM
Capitalization
65.2M
P/E Ratio
N/A
Risk (Beta)
1.27
Dividend Yield
N/A
Total Cash
153M
Total Cash/Share
7.34
Total Debt
73.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.05%
Revenue
1M
ROE
N/A
Book Value
144M
P/B Ratio
0.95
Cash Flow
N/A
Earnings
-5.95
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
5.82
Current Revenue Per Employee
8264.46
Dividends Per Share - Security
N/A
EBITDA
-99.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-43.66
Shares Held By Institutions
87.1M
Shares Outstanding - Current
20.9M
Total Liabilities
90.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-33.191
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel gene therapies to treat patients with sight-threatening ophthalmic diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Cardinal Way
Phone
+1 650 659-9323
Employees
121
Web
https://www.adverum.com